A detailed history of Ellsworth Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ellsworth Advisors, LLC holds 37,962 shares of JAZZ stock, worth $4.57 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
37,962
Previous 37,813 0.39%
Holding current value
$4.57 Million
Previous $4.21 Million 10.94%
% of portfolio
1.25%
Previous 1.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$107.32 - $127.74 $15,990 - $19,033
149 Added 0.39%
37,962 $4.68 Million
Q3 2024

Oct 16, 2024

BUY
$100.57 - $116.37 $63,560 - $73,545
632 Added 1.7%
37,813 $4.21 Million
Q2 2024

Jul 18, 2024

BUY
$103.94 - $118.98 $145,619 - $166,690
1,401 Added 3.92%
37,181 $3.97 Million
Q1 2024

Apr 15, 2024

BUY
$115.19 - $132.77 $4.12 Million - $4.75 Million
35,780 New
35,780 $4.31 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.54B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Ellsworth Advisors, LLC Portfolio

Follow Ellsworth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellsworth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellsworth Advisors, LLC with notifications on news.